Cargando…
Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes
We conducted a discovery genome-wide association study with expression quantitative trait loci (eQTL) annotation of new-onset diabetes (NOD) among European Americans, who were exposed to a calcium channel blocker-based strategy (CCB strategy) or a β-blocker-based strategy (β-blocker strategy) in the...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368017/ https://www.ncbi.nlm.nih.gov/pubmed/27670767 http://dx.doi.org/10.1038/tpj.2016.67 |
_version_ | 1782517853407150080 |
---|---|
author | Chang, Shin-Wen McDonough, Caitrin W. Gong, Yan Johnson, Todd A. Tsunoda, Tatsuhiko Gamazon, Eric R. Perera, Minoli A. Takahashi, Atsushi Tanaka, Toshihiro Kubo, Michiaki Pepine, Carl J. Johnson, Julie A. Cooper-DeHoff, Rhonda M. |
author_facet | Chang, Shin-Wen McDonough, Caitrin W. Gong, Yan Johnson, Todd A. Tsunoda, Tatsuhiko Gamazon, Eric R. Perera, Minoli A. Takahashi, Atsushi Tanaka, Toshihiro Kubo, Michiaki Pepine, Carl J. Johnson, Julie A. Cooper-DeHoff, Rhonda M. |
author_sort | Chang, Shin-Wen |
collection | PubMed |
description | We conducted a discovery genome-wide association study with expression quantitative trait loci (eQTL) annotation of new-onset diabetes (NOD) among European Americans, who were exposed to a calcium channel blocker-based strategy (CCB strategy) or a β-blocker-based strategy (β-blocker strategy) in the INternational VErapamil SR Trandolapril STudy. Replication of the top signal from the SNP*treatment interaction analysis was attempted in Hispanic and African Americans, and a joint meta-analysis was performed (total 334 NOD cases and 806 matched controls). PLEKHH2 rs11124945 at 2p21 interacted with antihypertensive exposure for NOD (meta-analysis p=5.3×10(−8)). rs11124945 G allele carriers had lower odds for NOD when exposed to the β-blocker strategy compared with the CCB strategy [OR=0.38 (0.24-0.60), p=4.0×10(−5)], while A/A homozygotes exposed to the β-blocker strategy had increased odds for NOD compared with the CCB strategy [OR=2.02 (1.39-2.92), p=2.0×10(−4)]. eQTL annotation of the 2p21 locus provides functional support for regulating gene expression. |
format | Online Article Text |
id | pubmed-5368017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-53680172017-03-28 Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes Chang, Shin-Wen McDonough, Caitrin W. Gong, Yan Johnson, Todd A. Tsunoda, Tatsuhiko Gamazon, Eric R. Perera, Minoli A. Takahashi, Atsushi Tanaka, Toshihiro Kubo, Michiaki Pepine, Carl J. Johnson, Julie A. Cooper-DeHoff, Rhonda M. Pharmacogenomics J Article We conducted a discovery genome-wide association study with expression quantitative trait loci (eQTL) annotation of new-onset diabetes (NOD) among European Americans, who were exposed to a calcium channel blocker-based strategy (CCB strategy) or a β-blocker-based strategy (β-blocker strategy) in the INternational VErapamil SR Trandolapril STudy. Replication of the top signal from the SNP*treatment interaction analysis was attempted in Hispanic and African Americans, and a joint meta-analysis was performed (total 334 NOD cases and 806 matched controls). PLEKHH2 rs11124945 at 2p21 interacted with antihypertensive exposure for NOD (meta-analysis p=5.3×10(−8)). rs11124945 G allele carriers had lower odds for NOD when exposed to the β-blocker strategy compared with the CCB strategy [OR=0.38 (0.24-0.60), p=4.0×10(−5)], while A/A homozygotes exposed to the β-blocker strategy had increased odds for NOD compared with the CCB strategy [OR=2.02 (1.39-2.92), p=2.0×10(−4)]. eQTL annotation of the 2p21 locus provides functional support for regulating gene expression. 2016-09-27 2018-01 /pmc/articles/PMC5368017/ /pubmed/27670767 http://dx.doi.org/10.1038/tpj.2016.67 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Chang, Shin-Wen McDonough, Caitrin W. Gong, Yan Johnson, Todd A. Tsunoda, Tatsuhiko Gamazon, Eric R. Perera, Minoli A. Takahashi, Atsushi Tanaka, Toshihiro Kubo, Michiaki Pepine, Carl J. Johnson, Julie A. Cooper-DeHoff, Rhonda M. Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title | Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title_full | Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title_fullStr | Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title_full_unstemmed | Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title_short | Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes |
title_sort | genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368017/ https://www.ncbi.nlm.nih.gov/pubmed/27670767 http://dx.doi.org/10.1038/tpj.2016.67 |
work_keys_str_mv | AT changshinwen genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT mcdonoughcaitrinw genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT gongyan genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT johnsontodda genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT tsunodatatsuhiko genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT gamazonericr genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT pereraminolia genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT takahashiatsushi genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT tanakatoshihiro genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT kubomichiaki genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT pepinecarlj genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT johnsonjuliea genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes AT cooperdehoffrhondam genomewideassociationstudyidentifiespharmacogenomiclocilinkedwithspecificantihypertensivedrugtreatmentandnewonsetdiabetes |